QIPT — Quipt Home Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $93.55m
- $178.82m
- $245.92m
- 56
- 93
- 17
- 56
Annual cashflow statement for Quipt Home Medical, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
R2020 September 30th | 2021 September 30th | 2022 September 30th | C2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.7 | -6.17 | 4.84 | -2.78 | -6.76 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 7.82 | 19.8 | 0.367 | 6.22 | 3.75 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.62 | -8.88 | -1.9 | -2.01 | -6.53 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 14 | 18.7 | 26.3 | 37 | 35.4 |
| Capital Expenditures | -0.091 | -5.05 | -9.16 | -6.85 | -10.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -7.76 | -12.8 | -33.3 | -76 | 0 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -7.85 | -17.8 | -42.5 | -82.8 | -10.3 |
| Financing Cash Flow Items | 5.44 | -1.27 | -4.92 | -6.42 | -1.16 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13.7 | 3.91 | -9.85 | 54.4 | -26.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 19.5 | 5.38 | -26.1 | 8.69 | -1.03 |